Fig. 1From: Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromesClinical significance of BM serum HA levels in MDS. Comparion of BM serum HA levels between normal controls and a MDS sub-groups classified according to IPSS, b MDS sub-groups classified according to WHO, c MDS sub-groups classified according to karyotypes. d Overall survival and e time to AML progression in MDS patients with high and low levels of BM serum HABack to article page